DMRA(Damora Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-25 | Jarrett Jennifer | Director, President and CEO | 公开市场买入 | 12,500 | $20.23 |
| 2026-07-06 | Winslow Garrett | General Counsel | 公开市场卖出 | 245 | $29.98 |
| 2026-01-02 | Schambye Hans T. | Chief Executive Officer | 公开市场卖出 | 700 | $21.38 |
| 2026-01-02 | Winslow Garrett | General Counsel | 公开市场卖出 | 255 | $21.38 |
| 2026-01-02 | Firmani Lori | Chief Financial Officer | 公开市场卖出 | 135 | $21.41 |
| 2025-07-03 | Schambye Hans T. | Chief Executive Officer | 公开市场卖出 | 735 | $3.38 |
| 2025-07-03 | Winslow Garrett | General Counsel | 公开市场卖出 | 260 | $3.39 |
| 2025-07-03 | Firmani Lori | Interim CFO | 公开市场卖出 | 147 | $3.39 |
| 2025-01-03 | Winslow Garrett | General Counsel | 公开市场卖出 | 471 | $5.60 |
| 2025-01-03 | Firmani Lori | Interim CFO | 公开市场卖出 | 261 | $5.63 |
| 2025-01-03 | Schambye Hans T. | Chief Executive Officer | 公开市场卖出 | 1,341 | $5.60 |